Line Sepsis in the ICU: Prevention, Diagnosis, and Management

Dennis G. Maki; Christopher J. Crnich

doi:10.1055/s-2003-37914

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2003; 24(1): 023-036
DOI: 10.1055/s-2003-37914

Line Sepsis in the ICU: Prevention, Diagnosis, and Management

Dennis G. Maki^1,2 , Christopher J. Crnich¹

¹Section of Infectious Diseases, Department of Medicine, University of Wisconsin Medical School, Madison, Wisconsin
²Infection Control Department and Center for Trauma and Life Support, University of Wisconsin Hospital and Clinics, Madison, Wisconsin

Abstract

ABSTRACT

Intravascular devices (IVDs) are universally employed in the intensive care unit. Although their use is essential for the administration of medications and IV fluids, they carry a substantial risk of infection, either from the device itself or from contamination of administered infusate. IVD-related infections lead to increased patient morbidity and mortality and excess costs, but they are preventable. The highest rates of IVD-related infection occur with central venous catheters (CVCs). Immunosuppression and other underlying illnesses further increase the risk of IVD-related infection. Coagulase-negative staphylococci, Staphylococcus aureus, and Candida spp. are the most frequent infecting organisms. The incidence of IVD-related infections may be minimized by simple measures, including maximal barrier precautions during CVC placement, specialized training for personnel placing IVDs, and use of chlorhexidine for cutaneous antisepsis. Management of line sepsis should include blood cultures, treatment with appropriate antibiotics or antifungals, and, in most cases, removal and culture of the IVD.

KEYWORDS

Intravascular catheters - sepsis - bloodstream infections - catheter-related sepsis - staphylococci

Full Text

References

REFERENCES

1 Crnich C J, Maki D G. The role of intravascular devices in sepsis. Curr Infect Dis Rep . 2001; 3 497-506
2 Maki D. The epidemiology and prevention of nosocomial bloodstream infections [abstract]. Paper presented at Programs and Abstracts of the Third International Conference on Nosocomial Infections, Washington DC, ASM Press, 1990
3 Maki D, Mermel L. Infections due to infusion therapy. In: Bennett JV, Brachman PS, eds. Hospital Infections 4th ed. Philadelphia: Lippincott-Raven 1998: 689-724
4 Mermel L A. Prevention of intravascular catheter-related infections. Ann Intern Med . 2000; 132 391-402
5 Kluger D, Maki D. The relative risk of intravascular device-related bloodstream infections with different types of intravascular devices in adults: a meta-analysis of 206 published studies [abstract]. Infect Control Hosp Epidemiol . 2000; 21 95-96
6 Safdar N, Maki D G. The risk of cather-related bloodstream infection with peripherally inserted central venous catheeters used in inpatients. Abstracts and Proceedings from the 41st International Conference of Antimicrobial Agents and Chemotherapy [abstract #K-1435]. Chicago, IL: ASM Press; 2001: 428
7 Safdar N, Maki D G. The incidence and pathogenesis of catheter-related bloodstream infection with arterial catheters. Abstracts and Proceedings from the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC, ASM Press, 2002
8 Safdar N, Maki D G. A review of risk factors for catheter-related bloodstream infection in patients with percutaneously-inserted, non-cuffed central venous catheters: implications for preventative strategies. Medicine . 2002; 81 466-479
9 Elishoov H, Or R, Strauss N, Engelhard D. Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients: a 5-year prospective study. Medicine . 1998; 77 83-101
10 Tacconelli E, Tumbarello M, Pittiruti M. Central venous catheter-related sepsis in a cohort of 366 hospitalised patients. Euro J Clin Microbiol Infect Dis . 1997; 16 203-209
11 Astagneau P, Maugat S, Tran-Minh T. Long-term central venous catheter infection in HIV-infected and cancer patients: a multicenter cohort study. Infect Control Hosp Epidemiol . 1999; 20 494-498
12 Tokars J I, Cookson S T, McArthur M A, Boyer C L, McGeer A J, Jarvis W R. Prospective evaluation of risk factors for bloodstream infection in patients receiving home infusion therapy. Ann Intern Med . 1999; 131 340-347
13 Merrer J, De Jonghe B, Golliot F. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA . 2001; 286 700-707
14 Robert J, Fridkin S K, Blumberg H M. The influence of the composition of the nursing staff on primary bloodstream infection rates in a surgical intensive care unit. Infect Control Hosp Epidemiol . 2000; 21 12-17
15 Maki D G. Nosocomial bacteremia: an epidemiologic overview. Am J Med . 1981; 70 719-732
16 Maki D G, Narans L L, Banton J. A prospective study of the pathogenesis of PICC-related bsi [abstract K-10]. Abstracts and Proceedings from the 38th Interscience Conference of Antimicrobial Agents and Chemotherapy. Washington DC, ASM Press 1999
17 Maki D G, Kluger D M, Crnich C J. The microbiology of intravascular device-related (IVDR) infection in adults: 1. An analysis of 159 prospective studies; 2. Implications for prevention and treatment [abstract]. Abstracts and Proceedings from the 40th Annual Meeting of the Infectious Disease Society of America. Chicago, IL: Infectious Disease Society of America 2002
18 Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. Morb Mortal Wkly Rep . 2002; 51(RR-10) 1-29
19 CDC. Monitoring hospital-acquired infections to promote patient safety: United States, 1990-1999. Morb Mortal Wkly Rep . 2000; 49 149-153
20 Maki D G. The use of antiseptics for handwashing by medical personnel. J Chemother . 1989; 1 (suppl 1) S3-11
21 Raad I I, Hohn D C, Gilbreath B J. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol . 1994; 15(4 Pt 1) 231-238
22 Tomford J W, Hershey C O, McLaren C E, Porter D K, Cohen D I. Intravenous therapy team and peripheral venous catheter-associated complications: a prospective controlled study. Arch Intern Med . 1984; 144 1191-1194
23 Soifer N, Borzak S, Edlin B R. Prevention of peripheral intravenous catheter complications with an intravenous therapy team: a randomized, controlled trial. Arch Intern Med . 1998; 158 473-477
24 Soifer N E, Borzak S, Edlin B R, Weinstein R A. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med . 1998; 158 473-477
25 Sherertz R J, Ely E W, Westbrook D M. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med . 2000; 132 641-648
26 Crnich C J, Maki D G. The promise of novel technology for the prevention of intravascular device-related bloodstream infection, I: Pathogenesis and short-term devices. Clin Infect Dis . 2002; 34 1232-1242
27 Crnich C J, Maki D G. The promise of novel technology for the prevention of intravascular device-related bloodstream infection, II: Long-term devices. Clin Infect Dis . 2002; 34 1362-1368
28 Clemence M A, Walker D, Farr B M. Central venous catheter practices: results of a survey. Am J Infect Control . 1995; 23 5-12
29 Chaiyakunapruk N, Veenstra D L, Lipsky B A, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med . 2002; 136 792-801
30 Maki D G, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters: gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA . 1987; 258 2396-2403
31 Madeo M, Martin C R, Turner C, Kirkby V, Thompson D R. A randomized trial comparing Arglaes (a transparent dressing containing silver ions) to Tegaderm (a transparent polyurethane dressing) for dressing peripheral arterial catheters and central vascular catheters. Intensive Crit Care Nurs . 1998; 14 187-191
32 Hanazaki K, Shingu K, Adachi W, Miyazaki T, Amano J. Chlorhexidine dressing for reduction in microbial colonization of the skin with central venous catheters: a prospective randomized controlled trial. J Hosp Infect . 1999; 42 165-168
33 Garland J S, Harris M C, Alex C P. A randomized trial comparing povidone-iodine to chlorhexidine gluconate impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics . 2001; 107 1431-1437
34 Maki D G, Mermel L A, Kluger D M. The efficacy of a chlorhexidine-impregnated sponge (biopatch) for the prevention of intravascular catheter-related infection: a prospective, randomized, controlled, multicenter trial [abstract #1430]. Abstracts and Proceedings from the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC, ASM Press, 2000
35 Maki D G, Stolz S M, Wheeler S, Mermel L A. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med . 1997; 127 257-266
36 Hanley E M, Veeder A, Smith T, Drusano G, Currie E, Venezia R A. Evaluation of an antiseptic triple-lumen catheter in an intensive care unit. Crit Care Med . 2000; 28 366-370
37 Veenstra D L, Saint S, Saha S, Lumley T, Sullivan S D. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA . 1999; 281 261-267
38 Veenstra D L, Saint S, Sullivan S D. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA . 1999; 282 554-560
39 Saint S, Veenstra D L, Lipsky B A. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful?. Infect Control Hosp Epidemiol . 2000; 21 375-380
40 Food and Drug Administration, Centers for Devices and Radiological Health. Potential hypersensitivity reactions to chlorhexidine-impregnated medical devices. Washington, DC: U.S. Food and Drug Administration; 1998 FDA public health notice available at: http:/www.fda.gov/cdrh/chlorhex.html. Accessed Sept. 26 2002
41 Oda T, Hamasaki J, Kanda N, Mikami K. Anaphylactic shock induced by an antiseptic-coated central venous catheter. Anesthesiol . 1997; 87 1242-1244
42 Raad I, Darouiche R, Dupuis J. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med . 1997; 127 267-274
43 Darouiche R O, Raad I I, Heard S O. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med . 1999; 340 1-8
44 Maki D G, Halvorson K T. Prospective study of the surface antimicrobial activity of commercially available medicated central venous catheters (CVCs)[abstract K-8]. Abstracts and Proceedings from the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC, ASM Press, 1998
45 Raad I, Darouiche R, Hachem R, Mansouri M, Bodey G P. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis . 1996; 173 418-424
46 Raad I I, Darouiche R O, Hachem R. Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin. Crit Care Med . 1998; 26 219-224
47 Brun-Buisson C, Nitenberg G, Doyon F. Randomized controlled trial of antiseptic-coated (ACC) central venous catheters [abstract #K-665]. Abstracts and Proceedings from the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC, ASM Press, 2002
48 Ramsey B W, Pepe M S, Quan J M. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med . 1999; 340 23-30
49 Martinez E, Collazos J, Mayo J. Hypersensitivity reactions to rifampin: pathogenetic mechanisms, clinical manifestations, management strategies, and review of the anaphylactic-like reactions. Medicine . 1999; 78 361-369
50 Sampath L, Tambe S, Modak S. Comparison of the efficacy of antiseptic and antibiotic catheters impregnated on both their luminal and outer surfaces [abstract #1917]. Abstracts and Proceedings from the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC, ASM Press, 1999
51 Mendelson M H, Short L J, Schechter C B. Study of a needleless intermittent intravenous-access system for peripheral infusions: analysis of staff, patient, and institutional outcomes. Infect Control Hosp Epidemiol . 1998; 19 401-406
52 Danzig L E, Short L J, Collins K. Bloodstream infections associated with a needleless intravenous infusion system in patients receiving home infusion therapy. JAMA . 1995; 273 1862-1864
53 Do A N, Ray B J, Banerjee S N. Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting. J Infect Dis . 1999; 179 442-448
54 Inoue Y, Nezu R, Matsuda H. Prevention of catheter-related sepsis during parenteral nutrition: effect of a new connection device. J Parenter Enteral Nutr . 1992; 16 581-585
55 Yebenes J C, Vidaur L, Martinez R. In vitro and in vivo evaluation of catheter infection (CI) risk using an uncovered disinfectable needleless valve connector for intravascular manipulation [abstract]. Abstracts and Proceedings from the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC, ASM Press, 2001
56 Schears G J, Liebeig C, Frey A M. StatLock catheter securement device significantly reduces central venous catheter complications (Abstract). Paper presented at: National Patient Safety Foundation and Joint Commission on Accreditation of Healthcare Organizations: Patient Safety Initiative: Spotlighting Strategies, Sharing Solutions, 2000; Chicago, IL
57 Yamamoto A J, Solomon J A, Soulen M C. Sutureless securement device reduces complications of peripherally inserted central venous catheters [abstract]. Abstracts and Proceedings from the 26th Annual Scientific Meeting of the Society of Cardiovascular and Interventional Radiologists, San Antonio, Texas, 2001
58 Henrickson K J, Axtell R A, Hoover S M. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J Clin Oncol . 2000; 18 1269-1278
59 Garland J S, Henrickson K J, Maki D G. A prospective randomized trial of vancomycin-heparin lock for prevention of catheter-related bloodstream infection in an NNICU [Abstract]. Pediatr Res . 2002; 51 A1734
60 O'Grady N P, Barie P S, Bartlett J. Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of America. Crit Care Med . 1998; 26 392-408
61 Mermel L A, Farr B M, Sherertz R J. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis . 2001; 32 1249-1272
62 Sprung C L, Bernard E B, Dellinger R P. Guidelines for the management of sepsis and shock. Intensive Care Med . 2001; 27(suppl 1) S1-S2
63 DesJardin J, Falagas M, Ruthazer R. Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer. Ann Intern Med . 1999; 131 641-647
64 Blot F, Nitenberg G, Chachaty E. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet . 1999; 35418 1071-1077
65 Telenti A, Steckelberg J M, Stockman L, Edson R S, Roberts G D. Quantitative blood cultures in candidemia. Mayo Clin Proc . 1991; 66 1120-1123
66 Douard M C, Arlet G, Longuet P. Diagnosis of venous access port-related infections. Clin Infect Dis . 1999; 29 1197-1202
67 Strinden W D, Helgerson R B, Maki D G. Candida septic thrombosis of the great central veins associated with central catheters: clinical features and management. Ann Surg . 1985; 202 653-658
68 Verghese A, Widrich W C, Arbeit R D. Central venous septic thrombophlebitis: the role of medical therapy. Medicine . 1985; 64 394-400
69 Maki D G. Managment of life-threatening infection in the intensive care unit. In: Murray MJ, Coursin DB, Pearl RG, Prough DS, eds. Critical Care Medicine: Preoperative Management 2nd ed. Philadelphia: Lippincott Williams & Williams 2002: 616-648
70 Raad I, Davis S, Khan A, Tarrand J, Elting L, Bodey G P. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia. Infect Control Hosp Epidemiol . 1992; 13 215-221
71 Groeger J S, Lucas A B, Thaler H T. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med . 1993; 119 1168-1174
72 Anaissie E J, Vartivarian S E, Abi-Said D. Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. Am J Med . 1996; 101 170-176
73 Rex J H, Bennett J E, Sugar A M. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med . 1994; 331 1325-1330
74 Rex J H, Bennett J E, Sugar A M. Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin Infect Dis . 1995; 21 994-996
75 Dugdale D C, Ramsey P G. Staphylococcus aureus bacteremia in patients with Hickman catheters. Am J Med . 1990; 89 137-141
76 Fowler Jr G V, Li J, Corey G R. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol . 1997; 30 1072-1078
77 Messing B, Man F, Colimon R, Thuillier F, Beliah M. Antibiotic lock technique is an effective treatment of bacterial catheter-related sepsis during parenteral nutrition. Clin Nutrition . 1990; 9 220-224
78 Douard M C, Arlet G, Leverger G. Quantitative blood cultures for diagnosis and management of catheter-related sepsis in pediatric hematology and oncology patients. Intensive Care Med . 1991; 17 30-35
79 Capdevila J A, Segarra A, Planes A M, Gasser I, Gavalda J, Pahissa A. Long-term follow-up of patients with catheter-related sepsis (CRS) treated without catheter removal [abstract]. Abstracts and Proceedings from the 35th Interscience Conference of Antimicrobial Agents and Chemotherapy. Washington DC, ASM Press, 1995
80 Krzywda E A, Andris D A, Edmiston Jr E C, Quebbeman E J. Treatment of Hickman catheter sepsis using antibiotic lock technique. Infect Control Hosp Epidemiol . 1995; 16 596-598
81 Albertyn L E, Alcock M K. Diagnosis of internal jugular vein thrombosis. Radiology . 1987; 162 505-508
82 Braun I F, Hoffman Jr C J, Malko J A, Pettigrew R I, Dannels W, Davis P C. Jugular venous thrombosis: MR imaging. Radiology . 1985; 157 357-360
83 Mori H, Fukuda T, Isomoto I, Maeda H, Hayashi K. CT diagnosis of catheter-induced septic thrombus of vena cava. J Comput Assist Tomog . 1990; 14 236-238
84 Maki D G, Agger W A. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine . 1988; 67 248-269
85 Raad I I, Sabbagh M F. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review. Clin Infect Dis . 1992; 14 75-82
86 Rosen A B, Fowler Jr G V, Corey G R. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann Intern Med . 1999; 130 810-820
87 Lecciones J A, Lee J W, Navarro E E. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis . 1992; 14 875-883
88 Phillips P, Shafran S, Garber G. Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group. Euro J Clin Microbiol Infect Dis . 1997; 16 337-345
89 Anaissie E J, Rex J H, Uzun O, Vartivarian S. Predictors of adverse outcome in cancer patients with candidemia. Am J Med . 1998; 104 238-245
90 Mora-duarte J, Betts R, Rotstein C. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med . 2002; 347 2020-2029
91 Rose H D. Venous catheter-associated candidemia. Am J Med Sci . 1978; 275 265-269
92 Terpenning M S, Buggy B P, Kauffman C A. Hospital-acquired infective endocarditis. Arch Intern Med . 1988; 148 1601-1603
93 Henderson D K, Edwards Jr E J, Montgomerie J Z. Hematogenous Candida endophthalmitis in patients receiving parenteral hyperalimentation fluids. J Infect Dis . 1981; 143 655-661